Published in J Nutr on February 10, 2010
Saturated long-chain fatty acids activate inflammatory signaling in astrocytes. J Neurochem (2012) 1.21
Docosahexaenoic acid (DHA): an ancient nutrient for the modern human brain. Nutrients (2011) 1.13
Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder. J Clin Psychopharmacol (2012) 1.05
Genetic risk prediction and neurobiological understanding of alcoholism. Transl Psychiatry (2014) 0.97
Convergent functional genomic studies of ω-3 fatty acids in stress reactivity, bipolar disorder and alcoholism. Transl Psychiatry (2011) 0.93
Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oil. Genes Nutr (2012) 0.91
n-3 polyunsaturated fatty acids supplementation enhances hippocampal functionality in aged mice. Front Aging Neurosci (2014) 0.83
Food intake and blood cholesterol levels of community-based adults with mood disorders. BMC Psychiatry (2012) 0.81
Functional and Structural Benefits Induced by Omega-3 Polyunsaturated Fatty Acids During Aging. Curr Neuropharmacol (2017) 0.76
The Relationship between Fatty Acids and Different Depression-Related Brain Regions, and Their Potential Role as Biomarkers of Response to Antidepressants. Nutrients (2017) 0.75
Effect of Omega-3 and -6 Supplementation on Language in Preterm Toddlers Exhibiting Autism Spectrum Disorder Symptoms. J Autism Dev Disord (2017) 0.75
Significance of long chain polyunsaturated fatty acids in human health. Clin Transl Med (2017) 0.75
The human orbitofrontal cortex: linking reward to hedonic experience. Nat Rev Neurosci (2005) 7.13
The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Prog Neurobiol (2004) 6.99
Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry (1999) 5.63
Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology. Bull World Health Organ (2000) 5.00
Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. Cereb Cortex (1997) 4.87
Regional brain volume abnormalities and long-term cognitive outcome in preterm infants. JAMA (2000) 4.49
Infant cerebral cortex phospholipid fatty-acid composition and diet. Lancet (1992) 3.90
Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry (2004) 3.43
Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord (2002) 3.28
Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry (2006) 3.01
Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century. Annu Rev Clin Psychol (2007) 2.61
Reduced volume of orbitofrontal cortex in major depression. Biol Psychiatry (2002) 2.53
Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J Neurotrauma (2004) 2.42
A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry (2007) 2.38
Omega-3 fatty acids and mood disorders. Am J Psychiatry (2006) 2.25
Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortex. Am J Psychiatry (2004) 2.24
Adolescents who were born very preterm have decreased brain volumes. Brain (2002) 1.97
Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull (2001) 1.83
Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr (1992) 1.80
Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry (1998) 1.73
Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids (2006) 1.71
Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder. Biol Psychiatry (2000) 1.68
Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J Neurochem (2004) 1.68
Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol Psychiatry (2006) 1.67
Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled, dose-ranging, functional magnetic resonance imaging study. Am J Clin Nutr (2010) 1.66
Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry (2009) 1.64
Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev (1980) 1.62
Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia. Stroke (2009) 1.62
Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opin Clin Nutr Metab Care (2007) 1.62
Omega-3 fatty acids and rodent behavior. Prostaglandins Leukot Essent Fatty Acids (2006) 1.61
Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord (1998) 1.54
Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: a cross-sectional study. Biol Psychiatry (2006) 1.47
Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J Neurosci (2007) 1.47
Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry (2006) 1.43
Reduction of orbital frontal cortex volume in geriatric depression. Biol Psychiatry (2000) 1.38
The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects. Brain Res Bull (2001) 1.37
Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression. Neuropsychopharmacology (2004) 1.36
A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. J Clin Psychiatry (2009) 1.33
Voxel-based study of structural changes in first-episode patients with bipolar disorder. Biol Psychiatry (2006) 1.32
Cell pathology in mood disorders. Semin Clin Neuropsychiatry (2002) 1.30
Prominent reduction in pyramidal neurons density in the orbitofrontal cortex of elderly depressed patients. Biol Psychiatry (2005) 1.24
Comparing age at onset of major depression and other psychiatric disorders by birth cohorts in five US community populations. Arch Gen Psychiatry (1991) 1.23
Decreased prefrontal Myo-inositol in major depressive disorder. Biol Psychiatry (2005) 1.22
Mode of action of mood stabilizers: is the arachidonic acid cascade a common target? Mol Psychiatry (2008) 1.21
Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neurosci Lett (2007) 1.20
Anatomic evaluation of the orbitofrontal cortex in major depressive disorder. Biol Psychiatry (2004) 1.20
Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection. Prostaglandins Leukot Essent Fatty Acids (2009) 1.19
Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder. Psychiatry Res (2008) 1.17
Extrauterine fatty acid accretion in infant brain: implications for fatty acid requirements. Early Hum Dev (1980) 1.16
Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder. Curr Opin Pharmacol (2006) 1.16
Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics. Mol Neurobiol (2005) 1.15
Evidence for orbitofrontal pathology in bipolar disorder and major depression, but not in schizophrenia. Bipolar Disord (2005) 1.15
Structural abnormalities of ventrolateral and orbitofrontal cortex in patients with familial bipolar disorder. Bipolar Disord (2009) 1.15
Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial. Eur Neuropsychopharmacol (2007) 1.12
Future of genetics of mood disorders research. Biol Psychiatry (2002) 1.11
Maternal dietary (n-3) fatty acid deficiency alters neurogenesis in the embryonic rat brain. J Nutr (2006) 1.11
Lower orbital frontal white matter integrity in adolescents with bipolar I disorder. J Am Acad Child Adolesc Psychiatry (2009) 1.10
Decrease in neuron size in docosahexaenoic acid-deficient brain. Pediatr Neurol (2002) 1.09
Depression, suicide and deficiencies of omega-3 essential fatty acids in modern diets. World Rev Nutr Diet (2009) 1.09
Polyunsaturated fatty acids induce ischemic and epileptic tolerance. Neuroscience (2002) 1.08
Metabolic pathways for glucose in astrocytes. Glia (1997) 1.06
Polyunsaturated fatty acid deficit in patients with bipolar mania. Eur Neuropsychopharmacol (2003) 1.05
Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression. Brain Behav Immun (2001) 1.05
Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. Eur J Clin Nutr (2009) 1.04
Subcortical lesion severity and orbitofrontal cortex volume in geriatric depression. Biol Psychiatry (2003) 1.03
Changing fatty acid content of growth cone lipids prior to synaptogenesis. J Neurochem (1992) 1.02
Preliminary evidence for progressive prefrontal abnormalities in adolescents and young adults with bipolar disorder. J Int Neuropsychol Soc (2009) 1.02
The aging human orbitofrontal cortex: decreasing polyunsaturated fatty acid composition and associated increases in lipogenic gene expression and stearoyl-CoA desaturase activity. Prostaglandins Leukot Essent Fatty Acids (2008) 0.99
Dietary n-3 fatty acid deficiency decreases nerve growth factor content in rat hippocampus. Neurosci Lett (2000) 0.98
(n-3) polyunsaturated fatty acid deficiency reduces the expression of both isoforms of the brain glucose transporter GLUT1 in rats. J Nutr (2005) 0.98
Glucose transport and utilization are altered in the brain of rats deficient in n-3 polyunsaturated fatty acids. J Neurochem (2002) 0.93
The influence of prematurity and long chain polyunsaturate supplementation in 4-week adjusted age baboon neonate brain and related tissues. Pediatr Res (2003) 0.92
Orbitofrontal cortex gray matter volumes in bipolar disorder patients: a region-of-interest MRI study. Bipolar Disord (2009) 0.91
Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. Am J Psychiatry (1997) 0.91
Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder. J Psychopharmacol (2006) 0.89
Delayed cell migration in the developing rat brain following maternal omega 3 alpha linolenic acid dietary deficiency. Neuroscience (2009) 0.88
Neuroprotective effect of developmental docosahexaenoic acid supplement against excitotoxic brain damage in infant rats. Neuroscience (2003) 0.88
Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model. Nutr Health (2006) 0.88
Docosahexaenoic acid (DHA) improves the age-related impairment of the coupling mechanism between neuronal activation and functional cerebral blood flow response: a PET study in conscious monkeys. Brain Res (2000) 0.87
Role of neuron-glia interaction in the regulation of brain glucose utilization. Diabetes Nutr Metab (2002) 0.87
The protective effects of omega-3 fatty acids against MK-801-induced neurotoxicity in prefrontal cortex of rat. Neurochem Int (2006) 0.86
Fatty acid composition of the postmortem prefrontal cortex of adolescent male and female suicide victims. Prostaglandins Leukot Essent Fatty Acids (2008) 0.85
Enhanced free radical scavenging and decreased lipid peroxidation in the rat fetal brain after treatment with ethyl docosahexaenoate. Biochim Biophys Acta (2001) 0.83
Gray and white matter brain volumes in older adults with bipolar disorder. Int J Geriatr Psychiatry (2009) 0.82
Perinatal n-3 fatty acid deficiency selectively reduces myo-inositol levels in the adult rat PFC: an in vivo (1)H-MRS study. J Lipid Res (2008) 0.82
Orbitofrontal cortex volumes in medication naïve children with major depressive disorder: a magnetic resonance imaging study. J Child Adolesc Psychopharmacol (2008) 0.81
Reductions in neuronal density in elderly depressed are region specific. Int J Geriatr Psychiatry (2009) 0.79